ECONSALUT

Critical comments on health economics and policy

09 de maig 2022

Pharma, big pharma (10)

›
 Inside the FDA: The Business and Politics Behind the Drugs We Take and the Food We Eat Inside the FDA takes a closer look at the practices,...
08 de maig 2022

Pharma, big pharma (9)

›
 Devalued and Distrusted: Can the Pharmaceutical Industry Restore its Broken Image? Starting with "4 Secrets that Drug Companies Don...
07 de maig 2022

Pharma, big pharma (8)

›
 Drug Truths: Dispelling the Myths About Pharma R & D This book answers the questions about the process and costs of pharmaceutical R ...
06 de maig 2022

Two-tier healthcare, or paying twice for the same (2)

›
 Are we heading for a two tier healthcare system in the UK? Private healthcare boom adds to fears of two-tier system in UK Extrapolation fro...
05 de maig 2022

Two-tier healthcare, or paying twice for the same

›
 Is Two-Tier Health Care the Future? In this book, leading researchers explore the public and private mix in Canada and within countries suc...
04 de maig 2022

Against black box medicine (2)

›
  Time to reality check the promises of machine learningowered precision medicine Both machine learning and precision medicine are genuine i...
03 de maig 2022

Pharmaceutical innovation

›
 El valor del medicamento desde una perspectiva social 2021
02 de maig 2022

"Going Dutch" in regulating the mandatory coverage (2)

›
 The market reform in Dutch health care: Results, lessons and prospects
01 de maig 2022

Reforming healthcare (2)

›
 Health system performance assessment: a framework for policy analysis
30 d’abril 2022

Medical device regulation

›
 The Future of Medical Device Regulation. Innovation and Protection
29 d’abril 2022

Capable governments as a precondition

›
  The Right Privatization. Why Private Firms in Public Initiatives Need Capable Governments
28 d’abril 2022

Provider payment strategies to improve health (2)

›
  Per un nou marc d’avaluació i contractació de serveis basat en el valor de la salut Our current payment system needs a complete overhaul. ...
27 d’abril 2022

Efficient health insurance as a first best

›
 Sick Insurance: Adverse Selection and Regulation of Health Insurance Markets When heterogeneity in consumer tastes and needs, and in cost a...
26 d’abril 2022

Against black box medicine

›
Explainable machine learning practices: opening another black box for reliable medical AI  In regulating medical AI, we should address not o...
‹
›
Inici
Visualitza la versió per a web
Pere Ibern
Visualitza el meu perfil complet
Amb la tecnologia de Blogger.